These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38970126)

  • 1. Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity.
    Zuppi M; Vatanen T; Wilson BC; Golovina E; Portlock T; Cutfield WS; Vickers MH; O'Sullivan JM
    Microbiome; 2024 Jul; 12(1):122. PubMed ID: 38970126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
    Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
    Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
    Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
    Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Horizontal gene transfer after faecal microbiota transplantation in adolescents with obesity.
    Behling AH; Wilson BC; Ho D; Cutfield WS; Vatanen T; O'Sullivan JM
    Microbiome; 2024 Feb; 12(1):26. PubMed ID: 38347627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
    Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
    PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: The Gut Bugs Randomized Controlled Trial.
    Leong KSW; Jayasinghe TN; Wilson BC; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    JAMA Netw Open; 2020 Dec; 3(12):e2030415. PubMed ID: 33346848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission.
    Majzoub ME; Paramsothy S; Haifer C; Parthasarathy R; Borody TJ; Leong RW; Kamm MA; Kaakoush NO
    Nat Commun; 2024 Oct; 15(1):8979. PubMed ID: 39420033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome.
    Manrique P; Zhu Y; van der Oost J; Herrema H; Nieuwdorp M; de Vos WM; Young M
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33794724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for the Gut Bugs Trial: a randomised double-blind placebo-controlled trial of gut microbiome transfer for the treatment of obesity in adolescents.
    Leong KSW; Jayasinghe TN; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Vatanen T; Holland DJ; O'Sullivan JM; Cutfield WS
    BMJ Open; 2019 Apr; 9(4):e026174. PubMed ID: 31005929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergence of gut phage communities but not bacterial communities following wild mouse bacteriophage transplantation into captive house mice.
    Čížková D; Payne P; Bryjová A; Ďureje Ľ; Piálek J; Kreisinger J
    ISME J; 2024 Jan; 18(1):. PubMed ID: 39276368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
    Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial.
    Ng SC; Xu Z; Mak JWY; Yang K; Liu Q; Zuo T; Tang W; Lau L; Lui RN; Wong SH; Tse YK; Li AYL; Cheung K; Ching JYL; Wong VWS; Kong APS; Ma RCW; Chow EYK; Wong SKH; Ho ICH; Chan PKS; Chan FKL
    Gut; 2022 Apr; 71(4):716-723. PubMed ID: 33785557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
    Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
    mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species- and strain-level assessment using
    Benítez-Páez A; Hartstra AV; Nieuwdorp M; Sanz Y
    Gut Microbes; 2022; 14(1):2078621. PubMed ID: 35604764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
    Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
    Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.